Kent, UK (PRWEB) March 28, 2014
Arrhythmia Alliance, a UK-based heart charity, estimates in excess of two million people in the UK suffer from heart arrhythmias. The symptoms can range from mild heart palpitations to collapse, with the most serious consequence being death. The most common heart arrhythmia is atrial fibrillation, which is associated with a five-fold increase in the risk of stroke.
The AliveCor Heart Monitor allows patients to self-manage their healthcare in a way that is not readily available in the NHS. It provides the patient low-cost, round-the-clock access to a cardiology rhythm specialist at a price point far below that of conventional private healthcare.
Patients can send diagnostic quality ECG recordings of their heart rhythms from the convenience of their mobile device equipped with the AliveCor Heart Monitor. Using AliveInsights(TM), an expert ECG analysis service, cardiac specialists review the recording and advise patients on their heart rhythm and whether medical intervention is required, for the low cost of 5 Pounds. The AliveECG app is available free of charge on both iOS and Android platforms.
AliveInsights changes the way patients and providers understand, collaborate and monitor cardiac health. Patients will now have a more holistic picture of their own cardiac health, be able to fully participate in making decisions about their health, while easily keeping their doctor’s up to date. This service also alerts patients when it is appropriate to seek urgent medical attention, giving patients peace of mind.
“Being able provide patients with a timely expert analysis of their cardiac health more efficiently and effectively is important to us as we work towards extending the reach of our ECG Cloud (R) services for cardiac patients and health professionals across the UK and Ireland” said Mark Hashemi, Managing Director of Technomed.
“We were impressed with Technomed’s efficient expert quality analysis service. AliveCor users will benefit from the ability to receive top quality cardiac assessments,” said Euan Thomson, president and chief executive officer of AliveCor. “This service offers clinical quality reports that helps empower patients to learn more about their own health and provide doctors with another tool to streamline their workflow and access expert ECG analysis.”
The AliveCor Heart Monitor received CE mark conformity in December 2012 and is the only mobile ECG interpretation recorder that supports both iOS and Android mobile devices. It records, displays, stores, and transfers single-channel ECG rhythms wirelessly, using the free AliveECG app. With secure storage in EU data-law compliant cloud, users can access their data confidentially anytime, anywhere, and can grant access to their doctor.
For more information about the AliveCor Heart Monitor including images of the device and software, please visit: http://www.alivecor.com.
Technomed Ltd is a privately held company headquartered in Tonbridge, Kent. The company is dedicated to the delivery of direct cardiology expertise to both general practice and patients alike. For more information visit http://www.technomedtelemedicine.co.uk
AliveCor, Inc., is a privately held company headquartered in San Francisco. The company is dedicated to enabling users to participate in their heart health through the use of the AliveCor(TM) Heart Monitor an innovative mobile health solution. For more information, please visit http://www.alivecor.com.
+1 (415) 795-9807
+44 (845) 5212 992